ATC level 3
L01CCancer medicines (antineoplastics), subgroup L01C
- Molecules
- 11
- Subgroups
- 5
ATC L01C (Cancer medicines (antineoplastics), subgroup L01C) is a level 3 group in the anatomical therapeutic chemical classification. The catalogue lists 11 molecules in it, each with brands, manufacturers and supply from India.
ATC codes are used as identifiers. Class names are written by MedsAcross and are not the WHO Collaborating Centre's text.
Subgroups
Molecules
Molecules with an ATC code under L01C.
- Cabazitaxel1 presentation3 brandsL01CD04
- DocetaxelMicrotubule Inhibitor14 presentations6 brandsL01CD02
- EtoposideTopoisomerase Inhibitor8 presentations3 brandsL01CB01
- IrinotecanOrphanTopoisomerase Inhibitor8 presentations3 brandsL01CE02
- PaclitaxelOrphanMicrotubule Inhibitor10 presentations8 brandsL01CD01
- TopotecanTopoisomerase Inhibitor5 presentations5 brandsL01CE01
- TrabectedinOrphanAlkylating Drug2 presentations4 brandsL01CX01
- VinblastineVinca Alkaloid1 presentationL01CA01
- VincristineOrphanVinca Alkaloid2 presentationsL01CA02
- Vinflunine1 brandL01CA05
- VinorelbineVinca Alkaloid2 presentationsL01CA04
For healthcare professionals and buyers. This is not medical advice. Treatment decisions belong to the prescriber.
Cannot find the medicine you need?
Our sourcing team can find unlisted, unapproved and hard-to-find medicines through licensed channels.